Published in Lancet Infect Dis on March 01, 2013
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol (2013) 4.38
Rethinking antioxidants in the intensive care unit. Am J Respir Crit Care Med (2013) 2.05
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev (2013) 1.72
Reactivation of multiple viruses in patients with sepsis. PLoS One (2014) 1.51
Macrophage polarization in inflammatory diseases. Int J Biol Sci (2014) 1.51
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care (2014) 1.48
Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis. PLoS Biol (2015) 1.40
The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med (2014) 1.30
Gene expression profiling in sepsis: timing, tissue, and translational considerations. Trends Mol Med (2014) 1.25
Lipid mediators in immune dysfunction after severe inflammation. Trends Immunol (2013) 1.24
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20
Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock. Am J Respir Crit Care Med (2014) 1.20
Pathophysiologic mechanisms in septic shock. Lab Invest (2013) 1.19
The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence (2013) 1.15
Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. J Biol Chem (2014) 1.11
Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol (2013) 1.09
Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis. Crit Care (2013) 1.09
Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI. Kidney Int (2015) 1.09
Timing and causes of death in septic shock. Ann Intensive Care (2015) 1.09
Immunology. Getting sepsis therapy right. Science (2015) 1.08
An Endotoxin Tolerance Signature Predicts Sepsis and Organ Dysfunction at Initial Clinical Presentation. EBioMedicine (2014) 1.05
Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care (2014) 1.04
Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma. Mediators Inflamm (2013) 1.04
The future of murine sepsis and trauma research models. J Leukoc Biol (2015) 1.04
The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp Neurol (2014) 1.02
Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis. Crit Care (2013) 1.00
MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect Immun (2014) 1.00
Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock (2015) 0.97
Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients. BMC Anesthesiol (2014) 0.96
The role of the liver in sepsis. Int Rev Immunol (2014) 0.95
Biomarkers of sepsis. Infect Chemother (2014) 0.95
Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology (2014) 0.94
Impact of sepsis on CD4 T cell immunity. J Leukoc Biol (2014) 0.94
Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care (2013) 0.94
Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsis. Shock (2013) 0.93
Mitochondria are gate-keepers of T cell function by producing the ATP that drives purinergic signaling. J Biol Chem (2014) 0.93
Patterns of gene expression in peripheral blood mononuclear cells and outcomes from patients with sepsis secondary to community acquired pneumonia. PLoS One (2014) 0.93
IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS. Shock (2016) 0.91
An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D. Mol Diagn Ther (2014) 0.91
Septic acute kidney injury: molecular mechanisms and the importance of stratification and targeting therapy. Crit Care (2014) 0.90
Relevance of Foxp3⁺ regulatory T cells for early and late phases of murine sepsis. Immunology (2015) 0.90
New paradigms in sepsis: from prevention to protection of failing microcirculation. J Thromb Haemost (2015) 0.89
How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit Care (2014) 0.89
Sepsis: Revising definitions of sepsis. Nat Rev Nephrol (2015) 0.89
Upregulation of GRAIL is associated with impaired CD4 T cell proliferation in sepsis. J Immunol (2014) 0.88
Modulation of respiratory dendritic cells during Klebsiella pneumonia infection. Respir Res (2013) 0.88
Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study. Crit Care (2016) 0.88
Sirt1 restrains lung inflammasome activation in a murine model of sepsis. Am J Physiol Lung Cell Mol Physiol (2015) 0.88
Association between heat shock protein 70 gene polymorphisms and clinical outcomes in intensive care unit patients with sepsis. Indian J Crit Care Med (2014) 0.87
BTLA as a biomarker and mediator of sepsis-induced immunosuppression. Crit Care (2013) 0.87
Modulation of monocytes in septic patients: preserved phagocytic activity, increased ROS and NO generation, and decreased production of inflammatory cytokines. Intensive Care Med Exp (2016) 0.87
Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function. Int J Mol Sci (2013) 0.86
Decreased serum concentrations of sphingosine-1-phosphate in sepsis. Crit Care (2015) 0.86
Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology. Cytokine (2014) 0.85
Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach. Intensive Care Med Exp (2014) 0.85
MITOCHONDRIAL FUNCTION IN SEPSIS. Shock (2016) 0.84
A Review of GM-CSF Therapy in Sepsis. Medicine (Baltimore) (2015) 0.84
Could Biomarkers Direct Therapy for the Septic Patient? J Pharmacol Exp Ther (2016) 0.84
Modulation of TNF-α mRNA stability by human antigen R and miR181s in sepsis-induced immunoparalysis. EMBO Mol Med (2014) 0.84
NFI-A disrupts myeloid cell differentiation and maturation in septic mice. J Leukoc Biol (2015) 0.83
Sepsis: From Pathophysiology to Individualized Patient Care. J Immunol Res (2015) 0.83
Suppression of T Cell Autophagy Results in Decreased Viability and Function of T Cells Through Accelerated Apoptosis in a Murine Sepsis Model. Crit Care Med (2017) 0.83
Diagnostics, therapy and outcome prediction in abdominal sepsis: current standards and future perspectives. Langenbecks Arch Surg (2013) 0.82
Differential alterations of tissue T-cell subsets after sepsis. Immunol Lett (2015) 0.82
Formal modelling of toll like receptor 4 and JAK/STAT signalling pathways: insight into the roles of SOCS-1, interferon-β and proinflammatory cytokines in sepsis. PLoS One (2014) 0.82
Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data. PLoS One (2013) 0.82
Immune response in severe infection: could life-saving drugs be potentially harmful? ScientificWorldJournal (2013) 0.82
Biology of sepsis: its relevance to pediatric nephrology. Pediatr Nephrol (2014) 0.82
Low B and T lymphocyte attenuator expression on CD4(+) T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort study. Crit Care (2015) 0.82
Monocyte HLA-DR in sepsis: shall we stop following the flow? Crit Care (2014) 0.82
The wingless-related integration site-5a/secreted frizzled-related protein-5 system is dysregulated in human sepsis. Clin Exp Immunol (2015) 0.82
Hydrogen gas presents a promising therapeutic strategy for sepsis. Biomed Res Int (2014) 0.81
CD1d- and MR1-Restricted T Cells in Sepsis. Front Immunol (2015) 0.81
Sepsis induces specific changes in histone modification patterns in human monocytes. PLoS One (2015) 0.81
Lipopolysaccharide modulates neutrophil recruitment and macrophage polarization on lymphatic vessels and impairs lymphatic function in rat mesentery. Am J Physiol Heart Circ Physiol (2015) 0.81
Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis. Crit Care (2014) 0.81
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD. J Am Soc Nephrol (2016) 0.80
Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome. PLoS One (2013) 0.80
AMP-activated protein kinase and Glycogen Synthase Kinase 3β modulate the severity of sepsis-induced lung injury. Mol Med (2015) 0.80
Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol (2015) 0.80
Palmitate differentially regulates the polarization of differentiating and differentiated macrophages. Immunology (2015) 0.80
Rab39a interacts with phosphatidylinositol 3-kinase and negatively regulates autophagy induced by lipopolysaccharide stimulation in macrophages. PLoS One (2013) 0.80
A conceptual framework: the early and late phases of skeletal muscle dysfunction in the acute respiratory distress syndrome. Crit Care (2015) 0.80
Role of circulating lymphocytes in patients with sepsis. Biomed Res Int (2014) 0.80
Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann Intensive Care (2017) 0.80
Relation between presence of extended-spectrum β-lactamase-producing Enterobacteriaceae in systematic rectal swabs and respiratory tract specimens in ICU patients. Ann Intensive Care (2017) 0.80
Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression. Pharmacol Res (2016) 0.79
Immunologic Consequences of Hypoxia during Critical Illness. Anesthesiology (2016) 0.79
Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. J Leukoc Biol (2016) 0.79
Mitochondrial Dysfunction, Depleted Purinergic Signaling, and Defective T Cell Vigilance and Immune Defense. J Infect Dis (2015) 0.79
Gender dimorphism of the cardiac dysfunction in murine sepsis: signalling mechanisms and age-dependency. PLoS One (2014) 0.79
Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study. Crit Care (2016) 0.79
Myeloid-derived suppressor cells in sepsis. Biomed Res Int (2014) 0.79
Common TLR1 genetic variation is not associated with death from melioidosis, a common cause of sepsis in rural Thailand. PLoS One (2014) 0.79
Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes. EBioMedicine (2015) 0.78
The Impact of HIV Co-Infection on the Genomic Response to Sepsis. PLoS One (2016) 0.78
Identification of biomarkers of response to IFNg during endotoxin tolerance: application to septic shock. PLoS One (2013) 0.78
S100A8/A9 mRNA induction in an ex vivo model of endotoxin tolerance: roles of IL-10 and IFNγ. PLoS One (2014) 0.78
Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling. J Leukoc Biol (2015) 0.78
Small-Volume Adenosine, Lidocaine, and Mg2+ 4-Hour Infusion Leads to 88% Survival after 6 Days of Experimental Sepsis in the Rat without Antibiotics. Clin Vaccine Immunol (2016) 0.78
Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 20.00
PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science (2001) 8.31
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol (2007) 7.60
Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med (1999) 7.24
Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA (2011) 7.10
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19
Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med (2009) 4.98
Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol (2001) 4.49
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A (2009) 4.23
Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA (2008) 4.19
The effect of age on the development and outcome of adult sepsis. Crit Care Med (2006) 4.08
Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet (1998) 3.71
Immunotherapy for sepsis--a new approach against an ancient foe. N Engl J Med (2010) 3.62
Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62
IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell (2011) 3.61
Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A (1999) 3.35
Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg (1977) 3.02
Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med (2008) 2.93
Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol (1999) 2.92
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother (2006) 2.86
Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J Leukoc Biol (2010) 2.81
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood (2010) 2.69
Bundled care for septic shock: an analysis of clinical trials. Crit Care Med (2010) 2.57
The pathogenesis of sepsis. Annu Rev Pathol (2011) 2.55
The search for effective therapy for sepsis: back to the drawing board? JAMA (2011) 2.46
Twelve immunotherapy drugs that could cure cancers. Immunol Rev (2008) 2.45
Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med (2009) 2.39
Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med (2008) 2.34
Mechanisms of sepsis-induced organ dysfunction. Crit Care Med (2007) 2.30
IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol (2010) 2.29
Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med (2007) 2.27
Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol (2011) 2.25
Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol (2002) 2.25
Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood (1995) 2.20
Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol (2005) 2.17
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS (2012) 2.02
Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med (2003) 1.98
Regulatory T cell populations in sepsis and trauma. J Leukoc Biol (2007) 1.96
Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med (2010) 1.95
Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg (2009) 1.95
IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J Immunol (2009) 1.91
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care (2011) 1.78
The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care (2011) 1.77
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care (2010) 1.73
Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clin Infect Dis (2012) 1.62
Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med (2007) 1.58
Sepsis studies need new direction. Lancet Infect Dis (2012) 1.50
The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets (2007) 1.47
A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J Infect Dis (1998) 1.41
A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care (2012) 1.41
IL-7 restores lymphocyte functions in septic patients. J Immunol (2012) 1.39
Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock (2003) 1.35
The rise and fall of drotrecogin alfa (activated). Lancet Infect Dis (2012) 1.32
Septic shock--evaluating another failed treatment. N Engl J Med (2012) 1.30
Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun (2010) 1.25
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. Aging Dis (2011) 1.23
IL-7 and IL-15: biology and roles in T-Cell immunity in health and disease. Crit Rev Immunol (2008) 1.22
Immunosuppression in sepsis. JAMA (2011) 1.22
BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction. J Leukoc Biol (2012) 1.22
Downregulation of CD40 ligand response in monocytes from sepsis patients. Clin Vaccine Immunol (2008) 1.20
After Xigris, researchers look to new targets to combat sepsis. Nat Med (2012) 1.15
A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia. J Antimicrob Chemother (2010) 1.14
Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels. Intensive Care Med (2002) 1.10
Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J Infect Dis (2012) 1.10
Spleen depletion in neonatal sepsis and chorioamnionitis. Am J Clin Pathol (2004) 1.08
Immunomodulatory therapy for sepsis: an update. Expert Rev Anti Infect Ther (2011) 1.08
Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production. Surgery (2000) 0.98
Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival. Target Oncol (2012) 0.98
Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit Care (2011) 0.97
Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients. J Microbiol Immunol Infect (2012) 0.97
B and T lymphocyte attenuator restricts the protective immune response against experimental malaria. J Immunol (2011) 0.94
Trial failure prompts soul-searching for critical-care specialists. Nat Med (2012) 0.90
Immune effects of interferon gamma in persistent staphylococcal sepsis. Am J Respir Crit Care Med (2012) 0.89
Community-acquired pneumonia: genomics, epigenomics, transcriptomics, proteomics, and metabolomics. Semin Respir Crit Care Med (2012) 0.86
Interleukin 7, maestro of the immune system. Semin Immunol (2012) 0.83
Mortality due to septic shock following early, appropriate antibiotic therapy: can we do better?*. Crit Care Med (2012) 0.80
Additional bad news from regulatory T cells in sepsis. Crit Care (2010) 0.79
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Sepsis in European intensive care units: results of the SOAP study. Crit Care Med (2006) 11.78
Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med (2012) 9.19
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol (2013) 4.38
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A (2009) 4.23
Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med (2014) 4.11
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med (2009) 3.30
Decompressive craniectomy and early cranioplasty for the management of severe head injury: a prospective multicenter study on 147 patients. World Neurosurg (2011) 2.89
Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke (2007) 2.62
Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med (2004) 2.51
Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med (2006) 2.47
The Eldicus prospective, observational study of triage decision making in European intensive care units. Part II: intensive care benefit for the elderly. Crit Care Med (2012) 2.46
The use of dabigatran in elderly patients. Arch Intern Med (2011) 2.43
Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med (2009) 2.39
Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med (2008) 2.34
Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med (2010) 2.31
High incidence of myocardial ischemia during postpartum hemorrhage. Anesthesiology (2004) 2.16
Influence of arterial dissolved oxygen level on venous oxygen saturation: don't forget the PaO2! Shock (2014) 2.14
A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock (2014) 2.11
Cytokine cascade in sepsis. Scand J Infect Dis (2003) 2.09
Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med (2005) 2.07
The pulmonary artery catheter: in medio virtus. Crit Care Med (2008) 2.01
Case scenario: Hemodynamic management of postoperative acute kidney injury. Anesthesiology (2013) 2.01
An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) study. Intensive Care Med (2006) 2.00
Regulatory T cell populations in sepsis and trauma. J Leukoc Biol (2007) 1.96
Functional hemodynamic monitoring. Crit Care (2005) 1.90
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care (2011) 1.78
Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem (2005) 1.74
Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care (2013) 1.74
Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med (2004) 1.73
The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med (2011) 1.72
Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med (2008) 1.72
Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med (2009) 1.69
International study on microcirculatory shock occurrence in acutely ill patients. Crit Care Med (2015) 1.64
Decreased T-cell repertoire diversity in sepsis: a preliminary study. Crit Care Med (2013) 1.62
Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol (2011) 1.60
Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med (2008) 1.59
The Eldicus prospective, observational study of triage decision making in European intensive care units: part I--European Intensive Care Admission Triage Scores. Crit Care Med (2012) 1.59
Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med (2007) 1.58
Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors. Neurosurgery (2008) 1.57
Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med (2005) 1.56
Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology (2002) 1.49
Factors associated with the mediastinal spread of cervical necrotizing fasciitis. Ann Thorac Surg (2011) 1.48
Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care (2010) 1.48
Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med (2014) 1.48
Delayed increase of S100A9 messenger RNA predicts hospital-acquired infection after septic shock. Crit Care Med (2011) 1.47
Prehospital noninvasive ventilation for acute respiratory failure: systematic review, network meta-analysis, and individual patient data meta-analysis. Acad Emerg Med (2014) 1.45
Lack of alteration of endogenous nitric oxide pathway during prolonged nitric oxide inhalation in intensive care unit patients. Crit Care Med (2005) 1.44
Effects of sepiapterin infusion on renal oxygenation and early acute renal injury after suprarenal aortic clamping in rats. J Cardiovasc Pharmacol (2011) 1.43
Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol (2006) 1.41
Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism*. Crit Care Med (2012) 1.41
IL-7 restores lymphocyte functions in septic patients. J Immunol (2012) 1.39
Arterial catheter-related bloodstream infections: results of an 8-year survey in a surgical intensive care unit. Crit Care Med (2011) 1.39
Early assessment of leukocyte alterations at diagnosis of septic shock. Shock (2010) 1.37
Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett (2006) 1.36
The role of the microcirculation in acute kidney injury. Curr Opin Crit Care (2009) 1.30
The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy (2005) 1.28
Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med (2007) 1.20
Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med (2005) 1.18
Understanding urine output in critically ill patients. Ann Intensive Care (2011) 1.18
Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med (2007) 1.18
Evaluation of an impedance threshold device in patients receiving active compression-decompression cardiopulmonary resuscitation for out of hospital cardiac arrest. Resuscitation (2004) 1.17
Bench-to-bedside review: Glucose and stress conditions in the intensive care unit. Crit Care (2010) 1.16
Consider delayed immunosuppression into the concept of sepsis. Crit Care Med (2008) 1.16
Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis. Crit Care (2011) 1.14
The response of the host microcirculation to bacterial sepsis: does the pathogen matter? J Mol Med (Berl) (2010) 1.13
Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One (2012) 1.13
Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumors. Lasers Surg Med (2011) 1.13
Concomitant assessment of PSP and NT-proCNP as predictive markers of sepsis in severe trauma patients under mechanical ventilation. Crit Care (2013) 1.12
Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care (2009) 1.12
Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg (2004) 1.11
Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol (2013) 1.09
Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leukoc Biol (2006) 1.09
Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol (2008) 1.09
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis (2014) 1.07
Management of renal replacement therapy in ICU patients: an international survey. Intensive Care Med (2012) 1.06
Effect of the AutoPulse automated band chest compression device on hemodynamics in out-of-hospital cardiac arrest resuscitation. Intensive Care Med (2010) 1.05
Extracranial complications in patients with acute brain injury: a post-hoc analysis of the SOAP study. Intensive Care Med (2008) 1.03
Fluid resuscitation does not improve renal oxygenation during hemorrhagic shock in rats. Anesthesiology (2010) 1.02
Use of the pulmonary artery catheter is not associated with worse outcome in the ICU. Chest (2005) 0.99
Real-time assessment of renal cortical microvascular perfusion heterogeneities using near-infrared laser speckle imaging. Opt Express (2010) 0.99
L-NIL prevents renal microvascular hypoxia and increase of renal oxygen consumption after ischemia-reperfusion in rats. Am J Physiol Renal Physiol (2009) 0.98
Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit Care (2011) 0.97
mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance. Crit Care (2011) 0.96
Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytometry B Clin Cytom (2012) 0.96
Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke (2008) 0.96
Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med (2011) 0.96
Use of an inspiratory impedance threshold device on a facemask and endotracheal tube to reduce intrathoracic pressures during the decompression phase of active compression-decompression cardiopulmonary resuscitation. Crit Care Med (2005) 0.96
Human monocytes differentiate into dendritic cells subsets that induce anergic and regulatory T cells in sepsis. PLoS One (2012) 0.96
Efficacy of selective arterial embolisation for the treatment of life-threatening post-partum haemorrhage in a large population. PLoS One (2008) 0.95
Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care (2013) 0.94
Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock. Shock (2004) 0.94
Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol (2005) 0.93
Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care (2010) 0.92
Noninvasive techniques for measurements of cardiac output. Curr Opin Crit Care (2005) 0.92
IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS. Shock (2016) 0.91
Adrenal response in patients with septic shock of abdominal origin: relationship to survival. Intensive Care Med (2007) 0.91